tobramycin and Burns
tobramycin has been researched along with Burns in 40 studies
Research
Studies (40)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (60.00) | 18.7374 |
| 1990's | 3 (7.50) | 18.2507 |
| 2000's | 5 (12.50) | 29.6817 |
| 2010's | 6 (15.00) | 24.3611 |
| 2020's | 2 (5.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Guo, B; Han, Y; Huang, Y; Mu, L; Zhao, X | 1 |
| Cheng, Z; Fan, X; Liu, X; Mi, Z; Wen, H; Zhang, H; Zhang, Y | 1 |
| Jeschke, M; Lee, C; Seto, W; Simor, A; Walker, SAN; Walker, SE | 1 |
| Davis, S; Doiron, A; Gil, J; Goodwine, J; Higa, A; Sauer, K; Solis, M; Valdes, J | 1 |
| Caceres, S; Caverly, L; Fratelli, C; Kim, SH; Malcolm, K; Moskowitz, S; Nichols, DP; Nick, JA; Poch, KR; Saavedra, M; Solomon, G; Taylor-Cousar, J | 1 |
| Bai, X; Gao, F; Gong, Y; Han, J; Hu, D; Li, J; Xu, J; Xu, M; Yang, X; Zhang, X; Zhu, H; Zhu, L | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Arnould, JF; Le floch, R; Pilorget, A | 2 |
| Akers, KS; Blatz, PJ; Boyer, JM; Chung, KK; Hospenthal, DR; Murray, CK; Okulicz, JF; Renz, EM | 1 |
| Ahmad, A; Gamelli, R; Hayek, B; Poulakidas, S | 1 |
| Bracco, D; Dubois, MJ; Eggimann, P; Landry, C | 1 |
| Cooper, EH; Meadows, T; Settle, JA; Yu, H | 1 |
| Chanturiia, TsK; Kharitonova, AM; Moroz, AF | 1 |
| Aoki, Y; Aoyama, H; Izawa, Y; Nishizaki, A; Okuda, J | 1 |
| Kluge, RM | 1 |
| Hall, G; Haynes, BW; Kline, BJ; Mayhall, CG; Polk, RE; Smith, J; Swensson, E | 1 |
| Brudzyńska-Charewicz, S; Bukowska, D; Grochowska, A; Nasiłowski, W; Serafińska, D; Zietkiewicz, W | 1 |
| Collins, RF; Edwards, LD; Franson, TR; Root, TE | 1 |
| Chen, JS; Liang, HP; Lu, LR; Sheng, ZY; Shi, ZG; Yao, YM; Yu, Y; Zhou, BT | 1 |
| Barret, JP; Herndon, DN; Jeschke, MG | 1 |
| Pennington, JE | 1 |
| Elwell, LP; Inamine, JM; Minshew, BH | 1 |
| Ratschow, R | 1 |
| Altemeier, WA; Hummel, RP; Miskell, PW | 1 |
| Minshew, BH; Pollock, HM; Schoenknecht, FD; Sherris, JC | 1 |
| Benn, RA | 1 |
| Baillet, A; Beaufils, F; Chapman, A; David, R; Loirat, P; Rohan, J | 1 |
| Hatala, M; Konícková, Z; Liska, M; Morávek, J; Prát, V; Schück, O | 1 |
| Currie, CA; Geheber, CE; Kolb, LD; Stone, HH | 1 |
| Baxter, CR; Horton, JW; Price, CI | 1 |
| Fasano, D; Palù, P; Papadia, F | 1 |
| Minukhin, VV; Tsyganenko, AIa | 2 |
| Klasen, HJ; Manson, WL; Sauër, EW; Westerveld, AW | 1 |
| Minukhin, VV; Tsyganenko, VIa | 1 |
| Aoyama, H; Izawa, Y; Nishizaki, A; Okuda, J | 1 |
| Csiba, A; Firr, M; Gráber, H; Novák, J; Syposs, T | 1 |
| Aoyama, H; Izawa, Y; Nishizaki, A; Okuda, J; Sunada, H | 1 |
| Besse, MD; Crépy, A; Galizia, JP; Goldstein, P; Marson, JC; Pellerin, P | 1 |
Reviews
2 review(s) available for tobramycin and Burns
| Article | Year |
|---|---|
Clinical aspects of pseudomonas infections.
Topics: Agammaglobulinemia; Blood Transfusion; Burns; Carbenicillin; Cystic Fibrosis; Drug Therapy, Combination; Endocarditis; Gentamicins; Granulocytes; Humans; Immunosuppression Therapy; Otitis Externa; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin; Urinary Catheterization; Urologic Diseases | 1981 |
[Antibiotics combination cefradin-tobramycin for the treatment of severe infections in trauma surgery].
Topics: Anti-Bacterial Agents; Burns; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Therapy, Combination; Emergency Medical Services; Fractures, Open; Humans; Infections; Osteomyelitis; Pneumonia; Surgical Wound Infection; Tobramycin; Urinary Tract Infections | 1979 |
Trials
3 trial(s) available for tobramycin and Burns
| Article | Year |
|---|---|
A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Burns; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies; Regression Analysis; Tobramycin; Young Adult | 2017 |
Selective decontamination of the digestive tract in severely burned pediatric patients.
Topics: Amphotericin B; Analysis of Variance; Bacteremia; Burns; Child; Cross Infection; Cytokines; Digestive System Diseases; Double-Blind Method; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Injury Severity Score; Intubation, Gastrointestinal; Linear Models; Male; Polymyxins; Probability; Prospective Studies; Reference Values; Survival Rate; Tobramycin; Treatment Outcome | 2001 |
Treatment of surgical infections with tobramcin.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Burns; Child; Child, Preschool; Drug Evaluation; Drug Resistance, Microbial; Female; Gentamicins; Humans; Infant; Infections; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Peritonitis; Surgical Procedures, Operative; Surgical Wound Infection; Time Factors; Tobramycin | 1975 |
Other Studies
35 other study(ies) available for tobramycin and Burns
| Article | Year |
|---|---|
Bacterial Growth-Induced Tobramycin Smart Release Self-Healing Hydrogel for
Topics: Anti-Bacterial Agents; Antioxidants; Burns; Chitosan; Escherichia coli; Humans; Hydrogels; Polymers; Pseudomonas aeruginosa; Pyrroles; Staphylococcal Infections; Tobramycin; Wound Healing; Wound Infection | 2022 |
Anti-Biofilm Enzymes-Assisted Antibiotic Therapy against Burn Wound Infection by Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biofilms; Burns; Communicable Diseases; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Wound Infection | 2023 |
Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Burns; Culture Media; Disease Models, Animal; Fermentation; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Pyruvic Acid; Staphylococcus aureus; Swine; Tobramycin | 2019 |
Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Burns; Ciprofloxacin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; Wound Infection | 2013 |
Selective decontamination of the digestive tract ameliorates severe burn-induced insulin resistance in rats.
Topics: Animals; Anti-Infective Agents; Blotting, Western; Burns; Colistin; Cytokines; Flucytosine; Gastrointestinal Microbiome; Gastrointestinal Tract; Glucose Tolerance Test; I-kappa B Kinase; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipopolysaccharides; Male; MAP Kinase Kinase 4; Permeability; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Tobramycin | 2015 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Which tobramycin dose is needed in the burn patient?
Topics: Anti-Bacterial Agents; Burns; Dose-Response Relationship, Drug; Humans; Tobramycin; Wound Infection | 2009 |
Nontuberculous mycobacterium infection in a burn ICU patient.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Burn Units; Burns; Cohort Studies; Fatal Outcome; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Tobramycin; Trachea | 2010 |
Orbital cellulitis in a burned child.
Topics: Anti-Bacterial Agents; Burns; Cellulitis; Drainage; Humans; Infant; Male; Methicillin Resistance; Orbital Diseases; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2005 |
Effect of systematic empiric treatment with imipenem on the bacterial ecology in a burns unit.
Topics: Anti-Bacterial Agents; Bacterial Infections; Burn Units; Burns; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Tobramycin | 2005 |
Pharmacokinetic variability of extended interval tobramycin in burn patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Burns; Creatinine; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas Infections; Tobramycin; Treatment Outcome; Wound Infection | 2008 |
Urinary protein profiles after burn injury.
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Albuminuria; Alpha-Globulins; beta 2-Microglobulin; Burns; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Infant; Kidney; Male; Middle Aged; Proteinuria; Retinol-Binding Proteins; Time Factors; Tobramycin | 1983 |
[Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
Topics: Animals; Anti-Bacterial Agents; Bacterial Vaccines; Burns; Drug Evaluation, Preclinical; Histocytochemistry; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors; Tobramycin | 1983 |
The effect of some ointment bases on the systemic absorption of tobramycin from various wound surfaces of burned patients.
Topics: Absorption; Adult; Aged; Burns; Female; Humans; Male; Middle Aged; Ointments; Petrolatum; Pharmaceutic Aids; Polyethylene Glycols; Tobramycin | 1984 |
Gentamicin and tobramycin penetration into burn eschar. Pharmacokinetics and microbiological effects.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Burns; Drug Therapy, Combination; Female; Gentamicins; Humans; Injections, Intravenous; Male; Middle Aged; Pseudomonas Infections; Tobramycin | 1983 |
[Effect of tobramycin on the bacterial flora of burn wounds].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Burns; Drug Resistance, Microbial; Humans; In Vitro Techniques; Skin; Tobramycin; Wound Infection | 1981 |
Treatment of twelve burn wound infections and eight other serious infections with cefazolin and tobramycin: in vitro and in vivo evaluation.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Burns; Cefazolin; Child; Child, Preschool; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Tobramycin; Wound Infection | 1980 |
Influence of selective decontamination of the digestive tract on cell-mediated immune function and bacteria/endotoxin translocation in thermally injured rats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Translocation; Burns; Cell Division; Cells, Cultured; Colistin; Digestive System; Disease Models, Animal; Endotoxins; Flucytosine; Immunity, Cellular; Immunosuppression Therapy; Interleukin-2; Intestines; Lymphocyte Subsets; Rats; Rats, Sprague-Dawley; Spleen; Tobramycin | 1997 |
Pseudomonas aeruginosa infection: pathogenesis and therapy.
Topics: Bacterial Vaccines; Burns; Carbenicillin; Cross Infection; Cystic Fibrosis; Gentamicins; Humans; Immunosuppression Therapy; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Tobramycin; Wound Infection | 1979 |
Common plasmid specifying tobramycin resistance found in two enteric bacteria isolated from burn patients.
Topics: Anti-Bacterial Agents; Burns; Chemical Phenomena; Chemistry; DNA, Bacterial; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Nucleic Acid Hybridization; R Factors; Tobramycin | 1978 |
Antibiotic resistance transfer from nonpathogenic to pathogenic bacteria.
Topics: Alcaligenes; Amikacin; Animals; Anti-Bacterial Agents; Burns; Drug Resistance, Microbial; Gentamicins; Germ-Free Life; Intestines; Mice; Mice, Inbred ICR; Pseudomonas aeruginosa; R Factors; Sisomicin; Tobramycin | 1977 |
Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Burns; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1977 |
Treatment of infections due to Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bronchopneumonia; Burns; Drug Therapy, Combination; Female; Humans; Middle Aged; Neutropenia; Osteochondritis; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections | 1977 |
Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Burns; Creatinine; Glomerular Filtration Rate; Half-Life; Humans; Inulin; Iodine Radioisotopes; Iothalamic Acid; Middle Aged; Tobramycin | 1978 |
Pharmacokinetics of tobramycin in rats with reduced renal parenchyma and in experimental shock.
Topics: Animals; Anti-Bacterial Agents; Burns; Gentamicins; Half-Life; Kidney; Kinetics; Nephrectomy; Rats; Shock, Septic; Tobramycin | 1976 |
Liposome delivery of aminoglycosides in burn wounds.
Topics: Animals; Anti-Bacterial Agents; Burns; Drug Carriers; Isotope Labeling; Liposomes; Rats; Rats, Inbred Strains; Tissue Distribution; Tobramycin | 1992 |
[Use of aztreonam in the perioperative prevention in burned patients].
Topics: Aztreonam; Burns; Drug Evaluation; Drug Therapy, Combination; Humans; Oxacillin; Premedication; Skin Transplantation; Tobramycin | 1990 |
[Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
Topics: Animals; Bacterial Vaccines; Burns; Combined Modality Therapy; Female; Immune Sera; Immunization, Passive; Macrophages; Male; Mice; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Wound Infection | 1989 |
Selective intestinal decontamination of the digestive tract for infection prophylaxis in severely burned patients.
Topics: Adult; Amphotericin B; Anti-Infective Agents; Burns; Digestive System; Drug Combinations; Drug Therapy, Combination; Humans; Polymyxins; Sulfamethoxazole; Tobramycin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Wound Infection | 1987 |
[Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
Topics: Animals; Bacterial Vaccines; Burns; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Immunization, Passive; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1986 |
[Dynamics of the contamination of mice during the treatment of burn sepsis due to Pseudomonas aeruginosa using tobramycin alone or combined with active and passive immunization].
Topics: Animals; Bacterial Vaccines; Burns; Combined Modality Therapy; Drug Evaluation, Preclinical; Immunization; Immunization, Passive; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1986 |
Optimal conditions for injection of tobramycin and cefmenoxime into burn patients.
Topics: Adult; Aged; Bacterial Infections; Burns; Cefmenoxime; Cefotaxime; Female; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Tobramycin | 1987 |
[Serum level of antibiotics in burn patients].
Topics: Adult; Aged; Anti-Bacterial Agents; Burns; Ceftazidime; Cephalexin; Gentamicins; Humans; Kinetics; Metabolic Clearance Rate; Middle Aged; Oxacillin; Tobramycin | 1986 |
Studies on systemic absorption of tobramycin in polyethylene glycol ointment applied to wounds of burn patients.
Topics: Administration, Topical; Adult; Burns; Female; Humans; Male; Middle Aged; Ointments; Polyethylene Glycols; Tobramycin | 1986 |
[The use of aminosides in the burn patient].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Burns; Humans; Netilmicin; Tobramycin | 1986 |